The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
about
The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The anti-rheumatic drug, leflu ...... n to suppress melanoma growth.
@en
The anti-rheumatic drug, leflu ...... n to suppress melanoma growth.
@nl
type
label
The anti-rheumatic drug, leflu ...... n to suppress melanoma growth.
@en
The anti-rheumatic drug, leflu ...... n to suppress melanoma growth.
@nl
prefLabel
The anti-rheumatic drug, leflu ...... n to suppress melanoma growth.
@en
The anti-rheumatic drug, leflu ...... n to suppress melanoma growth.
@nl
P2093
P2860
P356
P1433
P1476
The anti-rheumatic drug, leflu ...... n to suppress melanoma growth.
@en
P2093
Adam E Hendry
Darren W Sexton
Grant N Wheeler
Karamallah Al-Yousuf
Kimberley Hanson
Victoria Sherwood
P2860
P304
P356
10.18632/ONCOTARGET.23378
P407
P577
2017-12-17T00:00:00Z